Arcus Biosciences
RCUS
RCUS
128 hedge funds and large institutions have $756M invested in Arcus Biosciences in 2020 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 56 increasing their positions, 37 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
128
Holders Change
-11
Holders Change %
-7.91%
% of All Funds
2.59%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.04%
New
21
Increased
56
Reduced
37
Closed
31
Calls
$7.18M
Puts
$1.12M
Net Calls
+$6.06M
Net Calls Change
+$3.28M
Top Buyers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
FC
151
FORA Capital
Miami,
Florida
| – | -$134K | -5,408 | Closed |
|
152
UBS Group
Zurich,
Switzerland
| – | -$92K | -3,733 | Closed |
|
|
MAM
153
Meeder Asset Management
Dublin,
Ohio
| – | -$45K | -1,883 | Closed |
|
154
Acadian Asset Management
Boston,
Massachusetts
| – | -$24K | -954 | Closed |
|
|
VFA
155
Valeo Financial Advisors
Carmel,
Indiana
| – | -$6K | -228 | Closed |
|
|
CG
156
Cutler Group
San Francisco,
California
| – | -$2K | -100 | Closed |
|
157
US Bancorp
Minneapolis,
Minnesota
| – | -$1K | -44 | Closed |
|